Multipotent mesenchymal stem cells in renal transplantation
Open Access
- 27 March 2019
- journal article
- Published by IPO Association of Transplantologists in Transplantologiya
- Vol. 11 (1), 21-36
- https://doi.org/10.23873/2074-0506-2019-11-1-21-36
Abstract
Kidney transplantation is the most effective treatment for the end-stage chronic renal disease that has been observed to increase in the incidence consistently in recent years. Despite the achievements in immunosuppressive therapy in patients after renal transplantation, the graft survival length has remained unchangeable during the recent few decades. Bone marrow multipotent mesenchymal (stromal) stem cells (BM MMSCs) are known as a potential tool to influence this situation. Since their discovery in the middle of the XX century, their wide therapeutic potential in the transplantation of solid organs was demonstrated both in experimental and clinical trials. They have the ability to modify recipient’s immune response and improve postoperative course, however, having a low level of their own immunogenicity. MMSCs realize their properties through interactions both with the innate and adoptive immune system. Meanwhile, actual questions such as an optimal dosage and injection timing are still need answers. Actual experience of both experimental and clinical use of MMSCs in kidney transplantation has been analyzed in the present publication.Keywords
This publication has 70 references indexed in Scilit:
- Genomic responses in mouse models poorly mimic human inflammatory diseasesProceedings of the National Academy of Sciences of the United States of America, 2013
- Mesenchymal stem cells impair in vivo T-cell priming by dendritic cellsProceedings of the National Academy of Sciences of the United States of America, 2011
- Mesenchymal stem cell effects on T-cell effector pathwaysStem Cell Research & Therapy, 2011
- Mesenchymal Stromal Cells Engage Complement and Complement Receptor Bearing Innate Effector Cells to Modulate Immune ResponsesPLOS ONE, 2011
- Mesenchymal Stem Cells Inhibit Complement Activation by Secreting Factor HStem Cells and Development, 2010
- Mesenchymal stem cell–educated macrophages: A novel type of alternatively activated macrophagesExperimental Hematology, 2009
- Repair of Tissues by Adult Stem/Progenitor Cells (MSCs): Controversies, Myths, and Changing ParadigmsMolecular Therapy, 2009
- Cell contact, prostaglandin E2 and transforming growth factor beta 1 play non-redundant roles in human mesenchymal stem cell induction of CD4+CD25Highforkhead box P3+ regulatory T cellsClinical and Experimental Immunology, 2009
- Hematopoiesis: An Evolving Paradigm for Stem Cell BiologyCell, 2008
- Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statementCytotherapy, 2006